1. ACTR-12. PRELIMINARY SAFETY AND EFFICACY OF A PHASE II TRIAL OF 18F-DOPA PET-GUIDED, DOSE-ESCALATED RADIOTHERAPY IN THE TREATMENT OF GLIOBLASTOMA. (5th November 2018) Authors: Laack, Nadia; Pafundi, Deanna; Anderson, S; Hunt, Christopher; Zakhary, Mark; Kaufmann, Timothy; Wan Chan Tseung, Hok Seum; Lowe, Val; Yan, Elizabeth; Kizilbash, Sani; Uhm, Joon; Hu, Leland; Sarkaria, Jann; Brown, Paul D; Buckner, Jan; Brinkmann, Debra Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CBIO-18. TP53-MUTANT OLIGODENDROGLIOMA: A SINGLE INSTITUTION CASE SERIES. (12th November 2021) Authors: Webb, Mason; Kizilbash, Sani; Kollmeyer, Thomas; Jenkins, Robert; Sung, Sarah; Raghunathan, Aditya; Giannini, Caterina; Fung, Kar-Ming; Bouffard, John-Paul; Ida, Cristiane Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CLRM-14 INTRATUMORAL EXTRACELLULAR METABOLIC IMPACT OF DFMO AND AMXT 1501 IN LIVE HUMAN GLIOMAS. (5th August 2022) Authors: Riviere-Cazaux, Cecile; Neth, Bryan; Rahman, Masum; Kizilbash, Sani; Burns, Terry Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 1 Page Start: i9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTIM-10. A PHASE II STUDY OF RETIFANLIMAB (PD-1 INHIBITOR) IN COMBINATION WITH BEVACIZUMAB AND HYPOFRACTIONATED RADIOTHERAPY FOR RECURRENT GLIOBLASTOMA: NCT03532295. (14th November 2022) Authors: Butt, Omar; Huang, Jiayi; Luo, Jingqin; Tao, Yu; Strowd, Roy; Hissim, Deanna; Kizilbash, Sani; Abraham, Christopher; Anstass, George; Johanns, Tanner; Kim, Albert; Ciorba, Matthew; Chheda, Milan G; Campian, Jian Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CTNI-23. PRELIMINARY SAFETY AND PHARMACOKINETICS DATA FOR A PHASE 1B TRIAL OF TELAGLENASTAT IN COMBINATION WITH RADIATION THERAPY AND TEMOZOLOMIDE IN PATIENTS WITH IDH-MUTANT GRADE 2/3 ASTROCYTOMA (NCI-10218). (14th November 2022) Authors: Kizilbash, Sani; Piccioni, David; Sahebjam, Solmaz; Villano, John; Jaeckle, Kurt; Welch, Mary; Kong, Xiao-Tang; Holdhoff, Matthias; Lammers, Anita; Remick, Adam; Reid, Joel; Allred, Jacob; Port, John; Lanza, Ian; McBrayer, Samuel; Kunos, Charles; Shapiro, Geoffrey; Adjei, Alex Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CTNI-28. VOLUMETRIC AND DOSIMETRIC PATTERNS OF FAILURE ANALYSIS OF A PHASE II CLINICAL TRIAL OF 18F-DOPA-PET DIRECTED DOSE ESCALATED RADIOTHERAPY FOR GLIOBLASTOMA. (12th November 2021) Authors: Breen, William; Anderson, S Keith; Pafundi, Deanna; Kaufmann, Timothy; Hunt, Christopher; Lowe, Val; Vogen, Diane; Yan, Elizabeth; Sarkaria, Jann; Brown, Paul; Kizilbash, Sani; Uhm, Joon; Ruff, Michael; Zakhary, Mark; Zhang, Yan; Seaberg, Maasa; Rehim, Abdou Abdel; Tseung, Hok Seum Wan Chan; Qian... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EXTH-20. IDENTIFICATION OF EX VIVO THERAPEUTIC VULNERABILITIES IN DIFFUSE GLIOMAS USING A FUNCTIONAL GENOMICS APPROACH. (14th November 2022) Authors: Lin, Wan-Hsin; Smadbeck, James; Barrett, Michael; Feathers, Ryan; Dorsay, Sadeghian; Johnson, Sarah; Karagouga, Giannoula; Harris, Faye; Murphy, Stephen; Quiñones-Hinojosa, Alfredo; Kizilbash, Sani; Burns, Terry; Jaeckle, Kurt; Mrugala, Maciej; Bendok, Bernard; Moniz-Garcia, Diogo; Fortin-Ensign,... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Further understanding of glioma mechanisms of pathogenesis: implications for therapeutic development. Issue 5 (3rd May 2020) Authors: Ruff, Michael; Kizilbash, Sani; Buckner, Jan Journal: Expert review of anticancer therapy Issue: Volume 20:Issue 5(2020) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. INNV-15. MANAGEMENT AND LONG-TERM OUTCOMES OF ADULTS WITH MEDULLOBLASTOMA. (14th November 2022) Authors: Neth, Bryan; Raghunathan, Aditya; Kizilbash, Sani; Uhm, Joon; Breen, William; Johnson, Derek; Daniels, David; Sener, Ugur; Carabenciov, Ivan; Campian, Jian; Mahajan, Anita; Ruff, Michael Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. MNGI-06. EFFICACY OF 177LU-DOTATATE THERAPY IN RECURRENT ANAPLASTIC MENINGIOMA. (11th November 2019) Authors: Kizilbash, Sani; Johnson, Derek Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗